您当前的位置：
首页 >
文章列表页 >
circ_100284 via miR-217/MAPK1 regulates esophageal squamous cell carcinoma invasion and its effects on 5-FU chemotherapy sensitivity
Medical Journal of Chinese People′s Liberation Army   Vol. 49, Issue 10, Pages: 1184-1195(2024)
Basic Research | 更新时间：2024-11-07
|

    • circ_100284 via miR-217/MAPK1 regulates esophageal squamous cell carcinoma invasion and its effects on 5-FU chemotherapy sensitivity

    • “最新研究发现，环状RNA circ_100284通过miR-217/MAPK1通路影响食管癌侵袭和化疗敏感性，为食管癌治疗提供新思路。”

    • DOI：10.11855/j.issn.0577-7402.0787.2024.0201    

      CLC： R735.1

    • Published：28 October 2024，

      Published Online：01 February 2024，

      Received：06 June 2023，

      Accepted：15 August 2023

    移动端阅览

  • Shi Yan-Wei,Mi Cai-Feng,Niu Li-Lin,et al.circ_100284 via miR-217/MAPK1 regulates esophageal squamous cell carcinoma invasion and its effects on 5-FU chemotherapy sensitivity[J].Medical Journal of Chinese People′s Liberation Army,2024,49(10):1184-1195. DOI： 10.11855/j.issn.0577-7402.0787.2024.0201.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Research progress of the action mechanism of lncRNA UCA1 and miRNAs in digestive system tumors
The application and prospects of organoid technique in esophageal cancer research
Preliminary screening of chemotherapy-resistant genes in esophageal cancer and its clinical significance
Regulatory effects of thioredoxin on chemosensitivity of gastric cancer cells

Related Author

Niu Li-Lin
Mi Cai-Feng
Shi Yan-Wei
Wang Yu
Wang Si-Yu
ZHAO Tie-jun
ZHU Bo-rui
LI Chun-zhen

Related Institution

Department of Gastroenterology, the First Affiliated Hospital of Pingdingshan Medical College/Pingdingshan First People's Hospital
School of Basic Medicine, Shaanxi University of Chinese Medicine
Medical Research Experimental Center, Shaanxi University of Chinese Medicine
Department of Chest Surgery, Changhai Hospital of Navy Medical University of Chinese PLA
National Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
0